Ikena Oncology to Participate in the Piper Sandler 34th Annual Healthcare Conference
BOSTON, Nov. 22, 2022 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq:IKNA, “Ikena”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced that management will present a corporate overview and participate in 1×1 investor meetings at the Piper Sandler 34th Annual Healthcare Conference, taking place November 29-December 1, 2022, in New York, NY.
Related news for (IKNA)
- Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals
- 24/7 Market News Snapshot 15 July, 2025 – Ikena Oncology, Inc. Common Stock (NASDAQ:IKNA)
- Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement
- 24/7 Market News Snapshot 23 December, 2024 – Ikena Oncology, Inc. Common Stock (NASDAQ:IKNA)
- Ikena Oncology Discontinues Clinical IK-930 Program